Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Suggested Citation: "Part 3: Advancing Toward Better Malaria Control10 Research and Development for New Antimalarial Drugs." Institute of Medicine. 2004. Saving Lives, Buying Time: Economics of ...

Dr. Reddy’s and its CRDMO arm Aurigene Pharmaceutical Services have signed a non-binding Memorandum of Understanding with Kainomyx, a U.S.-based company with a platform that helps target cytoskeletal ...

GENEVA — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of ...

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects millions of people worldwide, including about 8–13% of reproductive-aged women, according to the World Health Organization.

Aminopeptidases constitute a diverse family of enzymes responsible for cleaving N‐terminal amino acids from peptide substrates, a process central to protein turnover and nutrient acquisition in ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. The findings, ...

Read full article: ‘Very scary incident:’ Central Florida woman escapes handcuffs, grabs officer’s gun GENEVA – Switzerland's medical products authority has granted the first approval for a malaria ...

The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers. In these diseases, a mutation in the genetic code ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - This 2014 photo made available by the U.S. Centers for Disease Control and Prevention shows a feeding female Anopheles ...